ArticleScientific reports2025
Spermatogenesis advancement in pre-pubertal meagre Argyrosomus regius treated with recombinant gonadotropins.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Histological Insights into Testicular Apoptosis Associated with Spermatogenesis in Pre-Pubertal and Adult Meagre (Animals : an open access journal from MDPI · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Τhe effects of recombinant meagre follicle stimulating hormone (rFsh) and luteinizing hormone (rLh) were evaluated on testicular maturation in pre-pubertal meagre Argyrosomus regius, an upcoming aquaculture species in the Mediterranean region. Fish (body mass 1092.9 ± 178.8 g) received seven weekly injections of meagre rFsh, together with an rLh injection at week 6. One group was further treated with weekly rFsh or rLh until week 11 and was sacrificed at week 12 (rFsh/rLh group, TREATED 12). The second group received further weekly injections of rFsh until week 12 and was then left untreated until week 21 (single rLh group, TREATED 21). Control fish received injections of saline solution. At week 12, the testes of the rFsh/rLh-treated fish (TREATED 12) showed increased gonadosomatic index and seminiferous tubule diameter, reduction of spermatogonial density, increase of post-meiotic spermatocysts and accumulation of luminal spermatozoa. In the single rLh-treated group (TREATED 21), apoptosis increased towards pre-treatment levels, demonstrating that the withdrawal of the Fsh stimulus ceased the process of spermatogenesis. The results demonstrated the effectiveness of rFsh/rLh treatment in stimulating testicular growth, spermiogenesis and spermiation in pre-pubertal meagre.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.